NOpiates: Novel dual action neuronal nitric oxide synthase inhibitors with μ-opioid agonist activity

ACS Medicinal Chemistry Letters

Volumn 3, Issue 3, 2012, Pages 227-231

  Renton, Paul ^a   Green, Brenda ^a,b   Maddaford, Shawn ^a   Rakhit, Suman ^a   Andrews, John S ^a  

^a NeurAxon Inc   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

benzimidazole; dual action; nitric oxide; NOpiate; NOpioid; NOS inhibitor; opioid

Indexed keywords

BENZIMIDAZOLE; CYCLIC AMP; LIGAND; MU OPIATE RECEPTOR AGONIST; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; BINDING AFFINITY; DRUG ACTIVITY; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; IC 50; PAIN; PRIORITY JOURNAL;

EID: 84858270496     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml200268w     Document Type: Article

References (36)

1. Candiotti, K. A.; Gitlin, M. C. Review of the effect of opioid related side effects on the undertreatment of moderate to severe chronic non-cancer pain: Tapentadol, a step toward a solution? Curr. Med. Res. Opin. 2010, 26, 1677-1684
2. Compton, W. M.; Volkow, N. D. Major increases in opioid analgesic abuse in the United States: Concerns and strategies Drug Alcohol Depend. 2006, 81, 103-107 (Pubitemid 41821793)
3. Woodcock, J.; Witter, J.; Dionne, R. A. Stimulating the development of mechanism-based, individualized pain therapies Nat. Rev. Drug Discovery 2007, 6, 703-710 (Pubitemid 47338179)
4. Dray, A.; Perkins, M. N. New pain treatments in late development. In Pharmacology of Pain; Beaulieu, P.; Lussier, D.; Porreca, F.; Dickenson, A. H., Eds.; IASP Press: Seattle, 2010; p 383.
5. Ulugol, A.; Aslantas, A.; Karadag, H. C.; Bulbul, E. D.; Tuncer, A.; Dokmeci, I. The effect of combined systemic administration of morphine and L-NAME, a NOS inhibitor, on behavioural signs of neuropathic pain in rats Neurosci. Res. Commun. 2002, 30, 143-153 and references cited therein (Pubitemid 34793049)
6. Chu, L. F.; Clark, D. J.; Angst, M. J. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: A preliminary prospective study J. Pain 2006, 7, 43-48 (Pubitemid 43097262)
7. Afilalo, M.; Stegman, J.-U.; Upmalis, D. Tapentadol immediate release: A new treatment option for acute pain management J. Pain Res. 2010, 3, 1-9
8. Hanlon, K. E.; Herman, D. S.; Agnes, R. S.; Largent-Milnes, T. M.; Kumarasinghe, I. R.; Ma, S. W.; Guo, W.; Lee, Y. S.; Ossipov, M. H.; Hruby, V. J.; Lai, J.; Porreca, F.; Vanderah, T. W. Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic pain Brain Res. 2011, 1395, 1-11
9. Richards, P; Riff, D.; Keen, R.; Stern, W. Analgesic and adverse effects of a fixed-ration morphine-oxycodone combination (MoxDuo) in the treatment of postoperative pain J. Opioid Manage. 2011, 7, 217-28
10. Daniels, D. J.; Lenard, N. R.; Etienne, C. L.; Law, P. Y.; Roerig, S. C.; Portoghese, P. S. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 19208-19213
11. Gilron, I.; Bailey, J. M.; Tu, D.; Holden, R. R.; Weaver, D. F.; Houlden, R. L. Morphine, Gabapentin, or their combination for neuropathic pain N. Engl. J. Med. 2005, 352, 1324-1334 (Pubitemid 40411499)
12. Frantz, S. The trouble with making combination drugs Nat. Rev. Drug Discovery 2006, 5, 881-882 (Pubitemid 44667856)
13. Wortman, M. Novel Pain Therapeutics: When Will Life Get Better on the Island of Pain? Start Up, April 2011, Elsevier Business Intelligence.
14. Morphy, R.; Rankovic, Z. Designed multiple ligands. An emerging drug discovery paradigm J. Med. Chem. 2005, 48, 1-21
15. Moncada, S.; Palmer, R. M. J.; Higgs, E. A. Nitric oxide: Physiology, pathophysiology, and pharmacology Pharmacol. Rev. 1991, 43, 109-142
16. Schmidtko, A.; Tegeder, I.; Geissleinger, G. No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing Trends Neurosci. 2009, 32, 339-346
17. Tao, F.; Tao, Y.-X.; Mao, P.; Zhao, C.; Li, D.; Liaw, W.-J.; Raja, S. N.; Johns, R. A. Intact carrageenan-induced thermal hyperalgesia in mice lacking inducible nitric oxide synthase Neuroscience 2003, 120, 847-854 (Pubitemid 36928081)
18. Hao, J.-X.; Xu, X.-J. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered nitric oxide synthase inhibitors Pain 1996, 66, 313-319 (Pubitemid 26284002)
19. Tanabe, M.; Nagatani, Y.; Saitoh, K.; Takasu, K.; Ono, H. Pharmacological assessments of nitric oxide synthase isoforms and downstream diversity of NO signaling in the maintenance of thermal and mechanical hypersensitivity after peripheral nerve injury in mice Neuropharmacology 2009, 56, 702-708
20. Toda, N.; Kishioka, S.; Hatano, Y.; Toda, H. Modulation of opioid actions by nitric oxide signaling Anesthesiology 2009, 110, 166-81
21. Heinzen, E. L.; Pollack, G. M. The development of morphine antinociceptive tolerance in nitric oxide synthase-deficient mice Biochem. Pharmacol. 2004, 67, 735-741 (Pubitemid 38125257)
22. Morphy, R.; Rankovic, Z. The physicochemical challenges of designing multiple ligands J. Med. Chem. 2006, 49, 4961-4970 (Pubitemid 44201054)
23. Hunger, A.; Keberle, J.; Rossi, A.; Hoffmann, K. Benzimidazol-derivate und verwandte heterocyclen III. Synthese von 1-aminoalkyl-2-nenzyl-nitro- benzimidazolen Helv. Chim. Acta 1960, 43, 1032-1046
24. Renton, P.; Speed, J.; Maddaford, S.; Annedi, S. C.; Ramnauth, J.; Rakhit, S. 1,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors Bioorg. Med. Chem. Lett. 2011, 21, 5301-5304
25. Maddaford, S.; Annedi, S. C.; Ramnauth, J.; Rakhit, S. Advancements in the developments of nitric oxide synthase inhibitors Annu. Rep. Med. Chem. 2009, 44, 27-50 and references cited therein
26. Feinberg, A. P.; Creese, I.; Snyder, S. H. The opiate receptor: A model explaining structure-activity relationships of opiate agonists and antagonists Proc. Natl. Acad. Sci. U.S.A. 1976, 73, 4215-4219
27. Burke, T. R.; Bajwa, B. S.; Jacobsen, A. E.; Rice, K. C.; Streaty, R. A.; Klee, W. A. Probes for narcotic receptor mediated phenonmena 7. Synthesis and pharmacological properties of irreversible ligands specific for μ or Î́ opiate receptors J. Med. Chem. 1984, 27, 1570-1574 (Pubitemid 15177895)
28. Lecolier, S. Nouveaux dialkylaminoalkyl-1 p-alkoxyphenyl alkyl-2 benzimidazoles 5-substitues. Fr. Patent FR1481049, 1967.
29. Porter, H. K. The Zinin reduction of nitroarenes Org. React. 1973, 20, 455-481
30. Carroll, F. I.; Coleman, M. C. Etonitazene. An improved synthesis J. Med. Chem. 1975, 18, 318-320
31. Wang, J. B.; Johnson, P. S.; Persico, A. M.; Hawkins, A. L.; Giffin, C. A.; Uhl, G. R. Human μ-opiate receptor. cDNA and genomic clones, pharmacological characterization and chromosomal assignment FEBS Lett. 1994, 338, 217-222 (Pubitemid 24064969)
32. Cayatte, A. J.; Palacino, J. J.; Horten, K.; Cohen, R. A. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits Arterioscler., Thromb., Vasc. Biol. 1994, 14, 753-759
33. Erdal, E. P.; Litzinger, E. A.; Seo, J.; Zhu, Y.; Ji, H.; Silverman, R. B. Selective neuronal nitric oxide synthase inhibitors Curr. Top. Med. Chem. 2005, 5, 603-624 (Pubitemid 41179723)
34. Maddaford, S. P.; Renton, P.; Speed, J.; Annedi, S. C.; Ramnauth, J.; Rakhit, S.; Andrews, J.; Mladenova, G.; Majuta, L.; Porreca, F. 1,6-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors Bioorg. Med. Chem. Lett. 2011, 21, 5234-5238
35. Raffa, R. B. A novel approach to the pharmacology of analgesics Am. J. Med. 1996, 101 (Suppl. 1A) 40S-46S (Pubitemid 26269075)
36. Tzschentke, T. M.; Christoph, T.; KoÌ̂gel, B.; Schiene, K.; Hennies, H. H.; Englberger, W.; Haurand, M.; Jahnel, U.; Cremers, T. I. F. H.; Friderichs, E.; De Vry, J. (â̂')-(1 R,2 R)-3-(3-Dimethylamino-1- ethyl-2-methyl-propyl)-phenol Hydrochloride (Tapentadol HCl): A Novel μ-Opioid Receptor Agonist/Norepinephrine Reuptake Inhibitor with Broad-Spectrum Analgesic Properties J. Pharmacol. Exp. Ther. 2007, 323, 265-276 (Pubitemid 47443277)